Screener
Wave Life Sciences WVE Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 507,508 | 614,814 |
| Long-term assets: | ||
| Property and equipment, net of accumulated depreciation of $50,819 and $49,522 as of June 30, 2026 and December 31, 2025, respectively | 6,833 | 7,405 |
| Operating lease right-of-use assets | 39,498 | 12,458 |
| Restricted cash | 3,815 | 3,806 |
| Other assets | 667 | 16 |
| Total long-term assets | 50,813 | 23,685 |
| Total assets | $558,321 | $638,499 |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's operating lease ROU assets?
- Wave Life Sciences (WVE) reported operating lease ROU assets of $39.5M in Q2 2026.
- How has Wave Life Sciences's operating lease ROU assets changed year-over-year?
- Wave Life Sciences's operating lease ROU assets increased by 159.0% year-over-year, from $15.25M to $39.5M.
- What is the long-term trend for Wave Life Sciences's operating lease ROU assets?
- Over 5 years (2020 to 2025), Wave Life Sciences's operating lease ROU assets has grown at a -5.2% compound annual growth rate (CAGR), from $16.23M to $12.46M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Wave Life Sciences's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude